LOS ANGELES, June 1 /PRNewswire/ -- The Elizabeth Glaser
Pediatric AIDS Foundation and Ty, Inc. today announced the
newest Beanie Baby created in memory of Elizabeth and Paul
Glaser's daughter, Ariel who died in 1988 from complications
from AIDS. All profits of Ty, Inc. from its sale will be
donated to the Foundation. Today, the new Ariel(TM) Beanie
Baby, which will be available in retail stores this month, will
be given away to all children currently admitted in the Mattel
Children's Hospital at UCLA.
"Our heartfelt appreciation goes to Ty Warner and all our
friends at Ty, Inc.," said Paul Glaser, chairman of the board,
the Elizabeth Glaser Pediatric AIDS Foundation. "The Ariel
Beanie Baby will help us raise awareness about the impact of
HIV and AIDS on babies, mothers and families around the world,
while raising critical funds for pediatric research. Every
day, 1,800 children are infected around the world. Clearly,
our work is far from over. Ty's extraordinary gift will help
us continue our quest to discover a vaccine and cure."
A painting created by Ariel, who spent much time painting and
drawing with her father, inspired the Ariel Beanie Baby. At
age five, Ariel painted how she envisioned the world -- as a
garden of beauty -- filled with sunshine and surrounded by
love. Today, her inspiration serves as the foundation's logo
representing hope for children everywhere.
"All of us at UCLA are deeply moved by today's extraordinary
partnership that will help continue the critical work of the
Elizabeth Glaser Pediatric AIDS Foundation," said Dr. Ed
McCabe, physician in chief of the Mattel Children's Hospital at
UCLA. "We salute the compassion and vision of Ty Warner that
will provide us invaluable resources to help us improve the
health of children here and around the world."
The Elizabeth Glaser Pediatric AIDS Foundation established its
reputation as the leading worldwide non-profit organization
dedicated to funding and conducting scientific research for
children with HIV/AIDS. When the Pediatric AIDS Foundation was
created in 1988, there was no coordinated research of the
disease's effect on children and none of the drugs used for
treating adults with AIDS were tested or approved for children.
Since then, the foundation has raised more than $100 million to
Today, the Elizabeth Glaser Pediatric AIDS Foundation continues
to build on its unique model of innovative and collaborative
scientific research to advance medical treatments for children.
The Foundation works to eliminate mother to child transmission,
to accelerate the discovery of new treatments for other serious
and life threatening diseases, and to ensure that children are
at the forefront of every scientific breakthrough.
SOURCE Elizabeth Glaser Pediatric AIDS Foundation
CONTACT: Carrie Hyun of the Elizabeth Glaser Pediatric AIDS
Foundation, 310-314-1459 or 202-427-7888; or Roxanne Moster,
Mattel Children's Hospital at UCLA, 310-794-2264/